Page 5 of 7
The Journal of Organic Chemistry
The stock solutions of Cinnamyl alcohol 1a (225mM,
3-Cinnamylbenzo[d]thiazol-2(3H)-one (3d). Colorless
solid, m.p. 46-47 oC, (EA/PE = 0 ~ 1/1, 125.5 mg, 94%). 5d 1
1
2
3
4
5
6
7
8
5.5mL) and 2-hydroxypyridine 2a-H (225mM, 5.5mL) were
prepared by directly dissolving their powers (1a, 166.4mg;
2a-H, 117.9mg) in 5.5 mL CDCl3, respectively. The
solutions of the 1a (Host) and 2a-H (Guest) were mixed to
NMR tubes according to certain proportions as
summarized in Table S1 and S2. The hydroxyl protons (–
OH) chemical shifts of both host (1a) and guest (2a-H)
were referenced to TMS. All 1H NMR spectra were
recorded at 600MHz 25K on a JNM-ECZ600R/S3 NMR
spectrometer.
General procedure for Host-guest interactions of
cinnamyl alcohol (1a) and 2-hydroxypyridine (2a-H)
by 1H NMR titration experiments. The stock solution of
Cinnamyl alcohol 1a (224mM, 800μL) was prepared by
directly dissolving 24.0 mg power in 800μL CDCl3. The
stock solution of 2-hydroxypyridine 2a-H (2.24M, 157μL)
was prepared by directly dissolving 33.5mg power in 157μL
CDCl3.
H
NMR (600 MHz, CDCl3) δ 7.47 – 7.42 (m, 1H), 7.36 – 7.31
(m, 1H), 7.31 – 7.27 (m, 2H), 7.24 – 7.21 (m, 3H), 7.16 (t, J =
7.4 Hz, 1H), 7.10 (d, J = 8.2 Hz, 1H), 6.60 (d, J = 15.9 Hz,
1H), 6.22 (dt, J = 15.9, 5.8 Hz, 1H), 4.73 (dd, J = 5.8, 1.5 Hz,
2H); 13C {1H} NMR (150 MHz, CDCl3) δ 170.0, 137.1, 136.0,
133.6, 128.7, 128.2, 126.6, 126.5, 123.3, 122.8, 122.7, 122.2, 111.2,
44.7; m/z (EI) : 267, 249, 234, 223, 212, 207, 193, 176, 165,
150, 136, 122, 117, 115, 106, 91, 78, 69, 65, 57, 54, 51.
(E)-3-(3-(4-Methoxyphenyl)allyl)quinazolin-4(3H)-
one (3e). Colorless solid, m.p. 122-124 oC, (EA/PE = 0 ~ 1/2,
125.5 mg, 86%). 16 1H NMR (600 MHz, CDCl3) δ 8.37 – 8.28
(m, 1H), 8.09 (s, 1H), 7.80 – 7.65 (m, 2H), 7.50 – 7.48 (m,
1H), 7.28 (dd, J = 9.0, 2.4 Hz, 2H), 6.81 (dd, J = 9.0, 2.4 Hz,
2H), 6.59 (d, J = 15.6 Hz, 1H), 6.18 (dt, J = 15.6, 6.6 Hz, 1H),
4.80 – 4.71 (m, 2H), 3.77 (s, 3H); 13C {1H} NMR (150 MHz,
CDCl3) δ 161.0, 159.8, 148.2, 146.3, 134.4, 134.2, 128.6, 128.0,
127.6, 127.4, 126.9, 122.2, 120.5, 114.1, 55.4, 48.4; m/z (EI) :
292, 280, 267, 261, 249, 235, 229, 207, 201, 191, 171, 147, 131,
115, 103, 91, 77, 63, 55, 51.
(E)-3-(3-(4-Fluorophenyl)allyl)quinazolin-4(3H)-one
(3f). Colorless solid, m.p. 110-111 oC, (EA/PE = 0 ~ 1/3, 126.0
mg, 90%).17 1H NMR (600 MHz, CDCl3) δ 8.33 – 8.26 (m,
1H), 8.06 (s, 1H), 7.76 – 7.64 (m, 2H), 7.47 (t, J = 7.2 Hz,
1H), 7.28 (dd, J = 8.4, 5.4 Hz, 2H), 6.95 (t, J = 8.4 Hz, 2H),
6.57 (d, J = 15.6 Hz, 1H), 6.22 (dt, J = 15.6, 6.6 Hz, 1H), 4.73
(d, J = 6.0 Hz, 2H); 13C {1H} NMR (150 MHz, CDCl3) δ 162.7
(d, J = 247.6 Hz), 161.0, 148.2, 146.2, 134.4, 133.3, 132.1 (d, J =
2.6 Hz), 128.3 (d, J = 7.8 Hz), 127.5 (d, J = 25.5 Hz), 126.8,
122.7, 122.2, 115.7 (d, J = 21.7 Hz), 48.2; m/z (EI) : 280, 265,
251, 232, 221, 207, 199, 191, 171, 165, 147, 135, 120, 115, 109, 102,
90, 83, 76, 63, 57, 50.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
500μL 1a stock solution was transferred to an NMR tube
and was titrated with 100 μL 2a-H (2.24M), added in 5μL
increments for 10 times and 10μL increments for 5 times,
and then with 32.1mg 2a-H powder, added in 10.7mg
increments for 3 times. The details were summarized in
Table S3. The chemical shift of hydroxyl protons (–OH) of
1
host (-OH of 1a) was referenced to TMS. All H NMR
spectra were recorded at 600 MHz 298 K on a JNM -
ECZ600R/S3 NMR spectrometer.
Typical Procedures for mild allylic substitution of
tautomerizable heteroarenes with allylic alcohols.
The mixture of cinnamyl alcohol 1a (80.4 mg, 0.60 mmol)
and 2-hydroxypyridine 2a-H (47.5 mg, 0.50 mmol),
[Pd(allyl)Cl]2 (4.6 mg, 2.5 mol%), dppf (13.8 mg, 10 mol%)
and cyclohexane (1.0 mL) was sealed in a Schlenk tube (20
mL) under N2, and stirred at 60 oC (oil bath) for 12 h. The
reaction was then monitored by TLC and/or GC-MS. After
completion of the reaction, the reaction mixture was
purified by flash column chromatography on silica gel
using ethyl acetate and petroleum ether (EA/PE = 0 ~ 1/1)
as the eluent, giving 3a in 90% isolated yield.
1-Cinnamylpyridin-2(1H)-one (3a). Colorless oil,
(EA/PE = 0 ~ 1/1, 95.0 mg, 90%).5d 1H NMR (600 MHz,
CDCl3) δ 7.35 (d, J = 7.4 Hz, 2H), 7.33 – 7.27 (m, 4H), 7.23
(dd, J = 8.2, 6.3 Hz, 1H), 6.65 – 6.51 (m, 2H), 6.29 (dt, J =
15.8, 6.5 Hz, 1H), 6.23 – 6.05 (m, 1H), 4.70 (dd, J = 6.3, 1.0
Hz, 2H); 13C {1H} NMR (150 MHz, CDCl3) δ 162.6, 139.6,
137.1. 136.1, 134.1, 128.7, 128.2, 126.7, 123.7, 121.2, 106.3, 50.8;
m/z (EI) : 211, 194, 182, 171, 152, 146, 133, 120, 117, 115, 102, 96,
91, 78, 65, 51.
(E)-3-(3-(4-Chlorophenyl)allyl)quinazolin-4(3H)-one
o
(3g). Colorless solid, m.p. 138-139 C, (EA/PE = 0 ~ 1/3,
1
136.1 mg, 92%). H NMR (600 MHz, CDCl3) δ 8.32 (dd, J =
8.4, 1.2 Hz, 1H), 8.07 (s, 1H), 7.78 – 7.74 (m, 1H), 7.71 (d, J =
7.8 Hz, 1H), 7.51 (t, J = 7.8 Hz, 1H), 7.28 – 7.23 (m, 4H),
6.58 (d, J = 15.6 Hz, 1H), 6.30 (dt, J = 15.6, 6.6 Hz, 1H), 4.77
13
(dd, J = 6.0, 1.2 Hz, 2H); C {1H} NMR (150 MHz, CDCl3) δ
161.0, 148.2, 146.2, 134.5, 134.3, 134.0, 133.2, 128.9, 127.9,
127.64, 127.55, 126.9, 123.6, 122.19, 48.2; m/z (EI) : 298, 297,
296, 281, 267, 253, 207, 191, 184, 176, 171, 151, 147, 125, 115, 102,
90, 76, 63, 58, 50. HRMS (ESI-TOF) m/z: (M+H)+ calcd for
C17H14ClN2O 297.0795, found 297.0807.
(E)-3-(3-(2-Methoxyphenyl)allyl)quinazolin-4(3H)-
one (3h). Colorless solid, m.p. 112-113 oC, (EA/PE = 0 ~ 1/2,
1
122.6 mg, 84%). H NMR (600 MHz, CDCl3) δ 8.31 (d, J =
7.8 Hz, 1H), 8.10 (s, 1H), 7.73 –7.68 (m, 2H), 7.47 (t, J = 7.8
Hz, 1H), 7.37 (d, J = 7.8 Hz, 1H), 7.23 – 7.18 (m, 1H), 6.99 (d,
J = 15.6 Hz, 1H), 6.89 – 6.80 (m, 2H,), 6.35 (dt, J = 15.6, 6.6
Hz, 1H), 4.77 (d, J = 6.6 Hz, 2H), 3.80 (s, 3H); 13C {1H} NMR
(150 MHz, CDCl3) δ 161.0, 156.9, 148.2, 146.4, 134.3, 130.0,
129.4, 127.6, 127.4, 127.3, 126.9, 124.8, 123.5, 122.3, 120.7, 110.9,
55.5, 48.8; m/z (EI) : 292, 280, 273, 249, 235, 229, 207, 201,
191, 171, 147, 131, 115, 103, 91, 77, 63, 55, 51. HRMS (ESI-TOF)
m/z: (M+H)+ calcd for C18H17N2O2 293.1290, found
293.1268.
3-Cinnamylquinazolin-4(3H)-one (3c). Colorless solid,
o
5d
m.p. 108-109 C, (EA/PE = 0 ~ 1/3, 123.5 mg, 94%). 1H
NMR (600 MHz, CDCl3) δ 8.34 – 8.29 (m, 1H), 8.08 (s, 1H),
7.75 – 7.68 (m, 2H), 7.50 – 7.46 (m, 1 H), 7.36 – 7.31 (m,
2H), 7.27 (t, J = 7.5 Hz, 2H), 7.24 – 7.20 (m, 1 H), 6.63 (d, J
= 15.9 Hz, 1H), 6.31 (dt, J = 15.8, 6.4 Hz, 1H), 4.75 (dd, J =
6.8, 1.1 Hz, 2H); 13C {1H} NMR (150 MHz, CDCl3) δ 161.0,
148.2, 146.3, 135.8, 134.5, 134.4, 128.7, 128.4, 127.6, 127.5,
126.9, 126.7, 122.9, 122.2, 48.3; m/z (EI) : 262, 247, 233, 216,
201, 191, 184, 171, 147, 130, 117, 115, 102, 91, 77, 63, 51.
1-Allylpyridin-2(1H)-one (3i). Colorless oil (EA/PE = 0 ~
8a
1/1, 55.3 mg, 82%).
1H NMR (600 MHz, CDCl3) δ 7.30
ACS Paragon Plus Environment